: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)

Free Medical Books

Breast Cancer

Free Subscription

Articles published in Breast Cancer Res Treat
Retrieve available abstracts of 492 articles:
HTML format
Text format

Single Articles

May 2012

XU J , Wan M, He Q, Bassett RL Jr, et al
SGK3 is associated with estrogen receptor expression in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

JACOT W , Pouderoux S, Thezenas S, Chapelle A, et al
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

ALSHAREEDA AT , Rakha EA, Nolan CC, Ellis IO, et al
Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

PESSETTO ZY , Yan Y, Bessho T, Natarajan A, et al
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

CLEMONS M , Russell K, Costa L, Addison CL, et al
Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SPEARS M , Pederson HC, Lyttle N, Gray C, et al
Expression of activated type I receptor tyrosine kinases in early breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

NIRAULA S , Ocana A, Ennis M, Goodwin PJ, et al
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

DEBEB BG , Cohen EN, Boley K, Freiter EM, et al
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LI T , Guo M, Gradishar WJ, Sparano JA, et al
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

NAROD SA , Valentini A, Nofech-Mozes S, Sun P, et al
Tumour characteristics among women with very low-risk breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

April 2012

HEIDEMANN S , Fischer C, Engel C, Fischer B, et al
Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

TOULMONDE M , Madranges N, Brouste V, Donamaria C, et al
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WORK ME , Andrulis IL, John EM, Hopper JL, et al
Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

NEUGUT AI , Hillyer GC, Kushi LH, Lamerato L, et al
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LI S , Yang X, Zhang Y, Fan L, et al
Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LEVY EW , Pfalzer LA, Danoff J, Springer BA, et al
Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

OTTINI L , Silvestri V, Rizzolo P, Falchetti M, et al
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SNAPE K , Ruark E, Tarpey P, Renwick A, et al
Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

HERTZ DL , Motsinger-Reif AA, Drobish A, Winham SJ, et al
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

YDE CW , Emdal KB, Guerra B, Lykkesfeldt AE, et al
NFkappaB signaling is important for growth of antiestrogen resistant breast cancer cells.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KORNEGOOR R , Moelans CB, Verschuur-Maes AH, Hogenes MC, et al
Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

YU KD , Zhou Y, Liu GY, Li B, et al
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SHEN J , Gammon MD, Terry MB, Bradshaw PT, et al
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SPYRATOS F , Valet F, Bieche I, Scott V, et al
Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

MATEJU M , Kleiblova P, Kleibl Z, Janatova M, et al
Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

JEFFE DB , Perez M, Liu Y, Collins KK, et al
Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

POWLES TJ , Diem SJ, Fabian CJ, Neven P, et al
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

YANG YL , Fan Y, Lang RG, Gu F, et al
Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

VAN HOESEL AQ , van de Velde CJ, Kuppen PJ, Liefers GJ, et al
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

ROULEAU E , Jesson B, Briaux A, Nogues C, et al
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

PESTRIN M , Bessi S, Puglisi F, Minisini AM, et al
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KIM SH , Sehrawat A, Singh SV
Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

ONITILO AA , Engel JM, Stankowski RV, Liang H, et al
High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LI H , Lin J, Wang X, Yao G, et al
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

CHENG CW , Wang HW, Chang CW, Chu HW, et al
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WU LM , Hu JN, Gu HY, Hua J, et al
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MUNZONE E , Botteri E, Sciandivasci A, Curigliano G, et al
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

March 2012

KAMAL AH , Camacho F, Anderson R, Wei W, et al
Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

VON MINCKWITZ G
Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

PEDRAZA AM , Pollan M, Pastor-Barriuso R, Cabanes A, et al
Disparities in breast cancer mortality trends in a middle income country.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SIKORA MJ , Strumba V, Lippman ME, Johnson MD, et al
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MERLO DF , Ceppi M, Filiberti R, Bocchini V, et al
Breast cancer incidence trends in European women aged 20-39 years at diagnosis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

POLLOCK CB , Koltai H, Kapulnik Y, Prandi C, et al
Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

VAN NES JG , Fontein DB, Hille ET, Voskuil DW, et al
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

HADJI P , Hartenfels M, Kyvernitakis J, Hars O, et al
Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES).
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

TRIPATHY D
Using neoadjuvant therapy for breast cancer in clinical practice: when and how?
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

MASSABEAU C , Sigal-Zafrani B, Belin L, Savignoni A, et al
The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KANG E , Park SK, Yang JJ, Park B, et al
Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MCALLISTER SD , Murase R, Christian RT, Lau D, et al
Erratum to: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

FOSTIRA F , Tsitlaidou M, Papadimitriou C, Pertesi M, et al
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

HARDEFELDT PJ , Eslick GD, Edirimanne S
Benign thyroid disease is associated with breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

CHEN LC , Tu SH, Huang CS, Chen CS, et al
Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

TCHOU J , Wang LC, Selven B, Zhang H, et al
Mesothelin, a novel immunotherapy target for triple negative breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

FERRALDESCHI R , Arnedos M, Hadfield KD, A'hern R, et al
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LIN NU , Winer EP, Wheatley D, Carey LA, et al
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

CARLSON RW , O'Neill A, Vidaurre T, Gomez HL, et al
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

ARSLAN AA , Silvera D, Arju R, Giashuddin S, et al
Atypical ezrin localization as a marker of locally advanced breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

AMIR E , Cecchini RS, Ganz PA, Costantino JP, et al
25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

CATUCCI I , Verderio P, Pizzamiglio S, Bernard L, et al
The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

BRUFSKY A , Valero V, Tiangco B, Dakhil S, et al
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

FRIESE CR
Disparities in breast cancer care delivery: solving a complex puzzle.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

IORFIDA M , Maiorano E, Orvieto E, Maisonneuve P, et al
Invasive lobular breast cancer: subtypes and outcome.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

XU F , Li D, Zhang Q, Fu Z, et al
Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MASCIARI S , Dillon DA, Rath M, Robson M, et al
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SON BH , Ahn SH, Kim SW, Kang E, et al
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

February 2012

CHEN X , Yuan Y, Gu Z, Shen K, et al
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

BERRANG TS , Lesperance M, Truong PT, Walter C, et al
Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer?
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LAMOND NW , Skedgel C, Rayson D, Lethbridge L, et al
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WANG N , Wang ZY, Mo SL, Loo TY, et al
Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SCHWARZENBACH H , Milde-Langosch K, Steinbach B, Muller V, et al
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

COLDITZ GA , Kaphingst KA, Hankinson SE, Rosner B, et al
Family history and risk of breast cancer: nurses' health study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

TEVAARWERK A , Burkard ME, Wisinski KB, Shafer MM, et al
Aromatase inhibitors and calcium absorption in early stage breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

SCHOPPMANN SF , Berghoff A, Dinhof C, Jakesz R, et al
Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MCCARTY CA , Reding DJ, Commins J, Williams C, et al
Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KROENKE CH , Michael Y, Tindle H, Gage E, et al
Social networks, social support and burden in relationships, and mortality after breast cancer diagnosis.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

RODRIGUES P , Furriol J, Tormo E, Ballester S, et al
The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KONDO M , Hoshi SL, Ishiguro H, Toi M, et al
Economic evaluation of the 70-gene prognosis-signature (MammaPrint((R))) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KOWALSKI C , Steffen P, Ernstmann N, Wuerstlein R, et al
Health-related quality of life in male breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KAPLAN CP , Kim SE, Wong ST, Sawaya GF, et al
Willingness to use tamoxifen to prevent breast cancer among diverse women.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

FERRALDESCHI R , Latif A, Clarke RB, Spence K, et al
Lack of caveolin-1 (P132L) somatic mutations in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles

CARDOSO MJ , Cardoso JS, Vrieling C, Macmillan D, et al
Recommendations for the aesthetic evaluation of breast cancer conservative treatment.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

TAKAHASHI S , Iwase T, Kohno N, Ishikawa T, et al
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

OUT AA , Wasielewski M, Huijts PE, van Minderhout IJ, et al
MUTYH gene variants and breast cancer in a Dutch case-control study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MU L , Tuck D, Katsaros D, Lu L, et al
Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

GRAVGAARD KH , Lyng MB, Laenkholm AV, Sokilde R, et al
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WU AH , Lorizio W, Tchu S, Lynch K, et al
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

January 2012

GIRGERT R , Emons G, Grundker C
Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KILBREATH SL , Refshauge KM, Beith JM, Ward LC, et al
Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WIGERTZ A , Ahlgren J, Holmqvist M, Fornander T, et al
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

LIPSCOMB J , Gillespie TW, Goodman M, Richardson LC, et al
Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

JOSHI D , Buehring GC
Are viruses associated with human breast cancer? Scrutinizing the molecular evidence.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

OLSHA O , Goldin I, Man V, Carmon M, et al
Ipsilateral hemodialysis access after axillary dissection for breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WEYCKER D , Barron R, Edelsberg J, Kartashov A, et al
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

JACQUIN JP , Jones S, Magne N, Chapelle C, et al
Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MAAE E , Olsen DA, Steffensen KD, Jakobsen EH, et al
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WHEELER SB , Carpenter WR, Peppercorn J, Schenck AP, et al
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

XU C , Langenheim JF, Chen WY
Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

ZHAO X , Mirza S, Alshareeda A, Zhang Y, et al
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KAJITANI K , Tanaka Y, Arihiro K, Kataoka T, et al
Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

FLEMING GF , Ma CX, Huo D, Sattar H, et al
Phase II trial of temsirolimus in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

KNOWER KC , To SQ, Takagi K, Miki Y, et al
Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

TAKEI H , Ohsumi S, Shimozuma K, Takehara M, et al
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

VALENTIN MD , da Silva SD, Privat M, Alaoui-Jamali M, et al
Molecular insights on basal-like breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

FUMAGALLI C , Pruneri G, Possanzini P, Manzotti M, et al
Methylation of O (6)-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

ABU AJAJ K , Graeser R, Kratz F
Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

FUNG TT , Schulze MB, Hu FB, Hankinson SE, et al
A dietary pattern derived to correlate with estrogens and risk of postmenopausal breast cancer.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WOOLCOTT CG , Koga K, Conroy SM, Byrne C, et al
Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WANG LE , Han CH, Xiong P, Bondy ML, et al
Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

MASALA G , Assedi M, Bendinelli B, Ermini I, et al
Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study.
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

WANG C , Uray IP, Mazumdar A, Mayer JA, et al
SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Breast Cancer Res Treat. 2012.
PubMed Text format Related articles Abstract available

December 2011

SCHWENTNER L , Wolters R, Koretz K, Wischnewsky MB, et al
Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival-a retrospective multi-centre cohort study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KOPPELMANS V , de Ruiter MB, van der Lijn F, Boogerd W, et al
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SANPAOLO P , Barbieri V, Genovesi D, Fusco V, et al
Biologically effective dose and breast cancer conservative treatment: is duration of radiation therapy really important?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

INAO T , Harashima N, Monma H, Okano S, et al
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KADI M , Wark PA, Gunter MJ, Riboli E, et al
Parity and mortality from causes other than breast cancer in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

RAMASWAMY B , Fiskus W, Cohen B, Pellegrino C, et al
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MARTIN RC , Robbins K, Fages JF, Romero FD, et al
Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MONTERO AJ , Avancha K, Gluck S, Lopes G, et al
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHEN J , Jiang Y, Liu X, Qin Z, et al
Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BEFORT CA , Klemp JR, Austin HL, Perri MG, et al
Outcomes of a weight loss intervention among rural breast cancer survivors.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ESSERMAN LJ , Berry DA, Cheang MC, Yau C, et al
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

RUGO HS , Jo Chien A, Franco SX, Stopeck AT, et al
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KWAN ML , Chen WY, Kroenke CH, Weltzien EK, et al
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GOGAS H , Dafni U, Karina M, Papadimitriou C, et al
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BEVIER M , Sundquist K, Hemminki K
Risk of breast cancer in families of multiple affected women and men.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

OPSTAL-VAN WINDEN AW , Vermeulen RC, Peeters PH, Beijnen JH, et al
Early diagnostic protein biomarkers for breast cancer: how far have we come?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BLACKBURN E , Zona S, Murphy ML, Brown IR, et al
A monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell lines.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SUETA A , Ito H, Kawase T, Hirose K, et al
A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JAIN S , Ward MM, O'Loughlin J, Boeck M, et al
Incremental increase in VEGFR1(+) hematopoietic progenitor cells and VEGFR2(+) endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MOUSSEAU Y , Mollard S, Faucher-Durand K, Richard L, et al
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DASGUPTA P , Baade PD, Aitken JF, Turrell G, et al
Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FRATI A , Chereau E, Coutant C, Bezu C, et al
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HERTEL PB , Tu D, Ejlertsen B, Jensen MB, et al
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BANEGAS MP , Gail MH, Lacroix A, Thompson B, et al
Evaluating breast cancer risk projections for Hispanic women.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LOWERY AJ , Kell MR, Glynn RW, Kerin MJ, et al
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MONTERO AJ , Diaz-Montero CM, Deutsch YE, Hurley J, et al
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DEMING SL , Lu W, Beeghly-Fadiel A, Zheng Y, et al
Melatonin pathway genes and breast cancer risk among Chinese women.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KNUDSEN ES , Ertel A, Davicioni E, Kline J, et al
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ROLLISON DE , Cole AL, Tung KH, Slattery ML, et al
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

November 2011

ZHENG Y , Ogundiran TO, Adebamowo C, Nathanson KL, et al
Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CERLIANI JP , Vanzulli SI, Pinero CP, Bottino MC, et al
Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KIDERLEN M , Bastiaannet E, Walsh PM, Keating NL, et al
Surgical treatment of early stage breast cancer in elderly: an international comparison.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AHMED MA , Aleskandarany MA, Rakha EA, Moustafa RZ, et al
A CD44(-)/CD24 (+) phenotype is a poor prognostic marker in early invasive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHANG M , Xu Y, Ouyang T, Li J, et al
Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BERNHOLTZ S , Laitman Y, Kaufman B, Shimon-Paluch S, et al
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SIMPSON NE , Tryndyak VP, Beland FA, Pogribny IP, et al
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GUGLIELMINI P , Rubagotti A, Boccardo F
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HATSCHEK T , Carlsson L, Einbeigi Z, Lidbrink E, et al
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JANSEN MP , Reijm EA, Sieuwerts AM, Ruigrok-Ritstier K, et al
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SHAABAN AM , Ball GR, Brannan RA, Cserni G, et al
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

IM SA , Lee KS, Ro J, Lee ES, et al
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VARGA Z , Moelans CB, Zuerrer-Hardi U, Ramach C, et al
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CABELLO C , Alvarenga M, Alvarenga CA, Duarte GM, et al
Case report and review of the literature: Secretory breast cancer in a 13-year-old boy-10 years of follow up.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GARTNER EM , Silverman P, Simon M, Flaherty L, et al
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WOLTERS R , Schwentner L, Regierer A, Wischnewsky M, et al
Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COLLINS LC , Marotti JD, Gelber S, Cole K, et al
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KIM JC , Yu JH, Cho YK, Jung CS, et al
Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FLORES ML , Castilla C, Avila R, Ruiz-Borrego M, et al
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHEN F , Bina WF
Correlation of white female breast cancer incidence trends with nitrogen dioxide emission levels and motor vehicle density patterns.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HIGGINS MJ , Prowell TM, Blackford AL, Byrne C, et al
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ANOTHAISINTAWEE T , Teerawattananon Y, Wiratkapun C, Kasamesup V, et al
Risk prediction models of breast cancer: a systematic review of model performances.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SANDRI MT , Salvatici M, Botteri E, Passerini R, et al
Prognostic role of CA15.3 in 7942 patients with operable breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ROCQUE G , Onitilo A, Engel J, Pettke E, et al
Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HAMIDULLAH , Changkija B, Konwar R
Role of interleukin-10 in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BLANCO A , de la Hoya M, Balmana J, Ramon Y Cajal T, et al
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PANIS C , Victorino VJ, Herrera AC, Freitas LF, et al
Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WEIGMAN VJ , Chao HH, Shabalin AA, He X, et al
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LUPORSI E , Andre F, Spyratos F, Martin PM, et al
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SOMLO G , Martel CL, Lau SK, Frankel P, et al
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CRANDALL CJ , Aragaki AK, Cauley JA, McTiernan A, et al
Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIAO SJ , Zhou YH, Yuan Y, Li D, et al
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes alphavbeta3-mediated adhesion and invasive migration.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BARDIA A , Arieas ET, Zhang Z, Defilippis A, et al
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BALTZELL K , Buehring GC, Krishnamurthy S, Kuerer H, et al
Epstein-Barr virus is seldom found in mammary epithelium of breast cancer tissue using in situ molecular methods.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

October 2011

FESTA-VASCONCELLOS JS , Piranda DN, Amaral LM, Indio-do-Brasil V, et al
Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TAM EK , Shen L, Munneke JR, Ackerson LM, et al
Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HARRIS HR , Bergkvist L, Wolk A
Folate intake and breast cancer mortality in a cohort of Swedish women.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KOLESNIKOV-GAUTHIER H , Vanlemmens L, Baranzelli MC, Vennin P, et al
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YUEN HF , Zhang SD, Wong AS, McCrudden CM, et al
Regarding "Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients"
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

JUSTENHOVEN C , Obazee O, Winter S, Couch FJ, et al
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

SHI H , Bevier M, Johansson R, Enquist-Olsson K, et al
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WILSON B , Sapp C, Abdeen G, Kamona A, et al
Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DORIA ML , Cotrim Z, Macedo B, Simoes C, et al
Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

RUBINEK T , Shulman M, Israeli S, Bose S, et al
Epigenetic silencing of the tumor suppressor klotho in human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MEADS C , Ahmed I, Riley RD
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NETA G , Anderson WF, Gilbert E, Berrington A, et al
Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GIRICZ O , Calvo V, Pero SC, Krag DN, et al
GRB7 is required for triple-negative breast cancer cell invasion and survival.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LAND LH , Dalton SO, Jensen MB, Ewertz M, et al
Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COTTU P , Marangoni E, Assayag F, de Cremoux P, et al
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MOHAMMADIANPANAH M , Ashouri Y, Hoseini S, Amadloo N, et al
The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AGBOOLA AJ , Paish EC, Rakha EA, Powe DG, et al
EpCAM expression is an indicator of recurrence in basal-like breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GODEY F , Leveque J, Tas P, Gandon G, et al
Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHANG Y
Need for clarification of data in the recent meta-analysis about TGFBR1*6A/9A polymorphism and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

BERGMANN A , Mendes VV, de Almeida Dias R, do Amaral E Silva B, et al
Incidence and risk factors for axillary web syndrome after breast cancer surgery.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HENRY NL , Clauw DJ
Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

CANDELARIA-QUINTANA D , Dayao ZR, Royce ME
The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

POHORELIC B , Singh R, Parkin S, Koro K, et al
Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

GUTH U , Myrick ME, Kilic N, Eppenberger-Castori S, et al
Compliance and persistence of endocrine adjuvant breast cancer therapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PIPPEN J , Paul D, Vukelja S, Clawson A, et al
Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HARTKOPF AD , Banys M, Krawczyk N, Staebler A, et al
Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HAN Y , Yu Z, Wen S, Zhang B, et al
Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LAM WW , Li WW, Bonanno GA, Mancini AD, et al
Trajectories of body image and sexuality during the first year following diagnosis of breast cancer and their relationship to 6 years psychosocial outcomes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COLONNA SV , Douglas Case L, Lawrence JA
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BREWER NT , Richman AR, Defrank JT, Reyna VF, et al
Improving communication of breast cancer recurrence risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

September 2011

WANG Y , Zhang C, Liu J, Huang G, et al
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MARME F , Werft W, Walter A, Keller S, et al
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HE ZY , Tong Q, Wu SG, Li FY, et al
A comparison of quality of life of early breast cancer patients treated with accelerated partial breast irradiation versus whole breast irradiation in China.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BURTON RC , Bell RJ, Thiagarajah G, Stevenson C, et al
Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DENEWER A , Farouk O, Kotb S, Setit A, et al
Quality of life among Egyptian women with breast cancer after sparing mastectomy and immediate autologous breast reconstruction: a comparative study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AHN ER , Vogel CL
Dual HER2-targeted approaches in HER2-positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KWAN ML , Sternfeld B, Ergas IJ, Timperi AW, et al
Change in physical activity during active treatment in a prospective study of breast cancer survivors.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHEN L , Zhou WB, Zhao Y, Liu XA, et al
Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ARNES JB , Stefansson IM, Straume O, Baak JP, et al
Vascular proliferation is a prognostic factor in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HAN D , Hogeveen S, Sweet Goldstein M, George R, et al
Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GU F , Kraft P, Rice M, Michels KB, et al
Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KIM HS , Woo OH, Park KH, Woo SU, et al
The relationship between twin births and maternal risk of breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LORTHOLARY A , Hardy-Bessard AC, Bachelot T, de Rauglaudre G, et al
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PANAGEAS KS , Sima CS, Liberman L, Schrag D, et al
Use of high technology imaging for surveillance of early stage breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WANG C , Mayer JA, Mazumdar A, Brown PH, et al
The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KIYOTANI K , Mushiroda T, Imamura CK, Tanigawara Y, et al
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HEIN R , Abbas S, Seibold P, Salazar R, et al
Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MA Y , Hao X, Zhang S, Zhang J, et al
The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AKBULUT S , Sogutcu N, Yagmur Y
Coexistence of breast cancer and tuberculosis in axillary lymph nodes: a case report and literature review.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VARADI V , Bevier M, Grzybowska E, Johansson R, et al
Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PONTIGGIA O , Sampayo R, Raffo D, Motter A, et al
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KOOLEN BB , Vrancken Peeters MJ, Aukema TS, Vogel WV, et al
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FLOWERS M , Fabrias G, Delgado A, Casas J, et al
C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BEASLEY JM , Kwan ML, Chen WY, Weltzien EK, et al
Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VESTJENS JH , de Boer M, van Diest PJ, van Deurzen CH, et al
Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIVAUDAIS JC , Hershman DL, Habel L, Kushi L, et al
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NG R , Lee CF, Wong NS, Luo N, et al
Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COCHET A , Quilichini G, Dygai-Cochet I, Touzery C, et al
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AIT-TIHYATY M , Rachid Z, Mihalcioiu C, Jean-Claude BJ, et al
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda((R)).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LONDONO-JOSHI AI , Oliver PG, Li Y, Lee CH, et al
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TOKUDA E , Seino Y, Arakawa A, Saito M, et al
Estrogen receptor-alpha directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PATANI N , Lambros MB, Natrajan R, Dedes KJ, et al
Non-existence of caveolin-1 gene mutations in human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TAYLOR S , Harley C, Ziegler L, Brown J, et al
Interventions for sexual problems following treatment for breast cancer: a systematic review.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HENDERSON VP , Clemow L, Massion AO, Hurley TG, et al
The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PATANI N , Martin LA, Reis-Filho JS, Dowsett M, et al
The role of caveolin-1 in human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HU F , Wang Yi B, Zhang W, Liang J, et al
Carotenoids and breast cancer risk: a meta-analysis and meta-regression.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YANG D , Zhao Y, Li AY, Wang S, et al
Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

OLIVER PG , Lobuglio AF, Zhou T, Forero A, et al
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHEN ML , Miaskowski C, Liu LN, Chen SC, et al
Changes in perceived attentional function in women following breast cancer surgery.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

POHORELIC B , Singh R, Parkin S, Koro K, et al
Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LUO T , Yan HM, He P, Luo Y, et al
Aspirin use and breast cancer risk: a meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GAJRIA D , Gonzalez J, Feigin K, Patil S, et al
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FERNANDEZ-DE-LAS-PENAS C , Fernandez-Lao C, Cantarero-Villanueva I, Ambite-Quesada S, et al
Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BROOKS JD , John EM, Mellemkjaer L, Reiner AS, et al
Body mass index and risk of second primary breast cancer: The WECARE Study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIGIBEL JA , James O'Malley A, Fisher M, Daniel GW, et al
Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

August 2011

PEURALA E , Koivunen P, Bloigu R, Haapasaari KM, et al
Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NALWOGA H , Arnes JB, Stefansson IM, Wabinga H, et al
Vascular proliferation is increased in basal-like breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CELLA D , Wang M, Wagner L, Miller K, et al
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DITE GS , Stone J, Chiarelli AM, Giles GG, et al
Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ITO T , Kamijo S, Izumi H, Kohno K, et al
Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LEE SA , Hwang SH, Ahn SG, Lee HM, et al
Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PARK DJ , Odefrey FA, Hammet F, Giles GG, et al
FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WALLWIENER CW , Wallwiener M, Kurth RR, Rohm C, et al
Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AHN SH , Kim HJ, Lee JW, Gong GY, et al
Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TVEDSKOV TF , Jensen MB, Kroman N, Balslev E, et al
Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HARVEY SL , Milne RL, McLachlan SA, Friedlander ML, et al
Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BLUMGART EI , Uren RF, Nielsen PM, Nash MP, et al
Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NOH JM , Choi DH, Nam SJ, Lee JE, et al
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NEKHLYUDOV L , Li L, Ross-Degnan D, Wagner AK, et al
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WHEELER SB , Carpenter WR, Peppercorn J, Schenck AP, et al
Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SATHIAKUMAR N , Delzell E, Morrisey MA, Falkson C, et al
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WANG Y , Yin Q, Yu Q, Zhang J, et al
A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHO YH , Shen J, Gammon MD, Zhang YJ, et al
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LOIBL S , Muller BM, von Minckwitz G, Schwabe M, et al
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZENG H , Irwin ML, Lu L, Risch H, et al
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

IWAMOTO T , Lee JS, Bianchini G, Hubbard RE, et al
First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BAEK JM , Jin Q, Ensor J, Boulbes DR, et al
Serum CD44 levels and overall survival in patients with HER2-positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SMITH I , Pierga JY, Biganzoli L, Cortes-Funes H, et al
Final overall survival results and effect of prolonged (>/=1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TAMIMI RM , Colditz GA, Hazra A, Baer HJ, et al
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ELLBERG C , Jernstrom H, Olsson H
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BAYRAKTAR S , Gutierrez-Barrera AM, Liu D, Tasbas T, et al
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIVINGSTON RB , Barlow WE, Kash JJ, Albain KS, et al
SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ABDEL-MAKSOUD MF , Risendal BC, Slattery ML, Giuliano AR, et al
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VILASCO M , Communal L, Mourra N, Courtin A, et al
Glucocorticoid receptor and breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CROKER AK , Allan AL
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDH(hi)CD44 (+) human breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NOGUCHI M , Inokuchi M, Ohno Y, Yokoi-Noguchi M, et al
Oncological and cosmetic outcome in breast cancer patients undergoing "moving window" operation.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KRIJGSMAN O , Roepman P, Zwart W, Carroll JS, et al
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MACKIEWICZ M , Huppi K, Pitt JJ, Dorsey TH, et al
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PANIS C , Herrera AC, Victorino VJ, Campos FC, et al
Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HE M , Di GH, Cao AY, Hu Z, et al
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BREWSTER AM , Etzel C, Zhou R, Wong Y, et al
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DU Y , Zhou Q, Yin W, Zhou L, et al
The role of topoisomerase IIalpha in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

July 2011

LANDWEHR R , Bogdanova NV, Antonenkova N, Meyer A, et al
Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AOGI K , Masuda N, Ohno S, Oda T, et al
First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MOURA V , Lacerda M, Figueiredo P, Corvo ML, et al
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VAN NES JG , de Kruijf EM, Putter H, Faratian D, et al
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MASSARWEH S , Tham YL, Huang J, Sexton K, et al
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LEE S , Ahn HK, Park YH, Nam DH, et al
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KOH WP , Van Den Berg D, Jin A, Wang R, et al
Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WARREN ANDERSEN S , Newcomb PA, Hampton JM, Titus-Ernstoff L, et al
Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GYORFFY B , Benke Z, Lanczky A, Balazs B, et al
RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SUNG H , Lee KM, Choi JY, Han S, et al
Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SUCHESTON LE , Zhao H, Yao S, Zirpoli G, et al
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LECARPENTIER J , Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, et al
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AHMED RL , Schmitz KH, Prizment AE, Folsom AR, et al
Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MA X , Kundu N, Collin PD, Goloubeva O, et al
Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HUANG KT , Takano EA, Mikeska T, Byrne DJ, et al
Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YOSHIMOTO N , Toyama T, Takahashi S, Sugiura H, et al
Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CREIGHTON CJ , Sada YH, Zhang Y, Tsimelzon A, et al
A gene transcription signature of obesity in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

POLLARI S , Kakonen SM, Edgren H, Wolf M, et al
Erratum to: Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ZAMBETTI M , Mansutti M, Gomez P, Lluch A, et al
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GUTH U , Myrick ME, Schotzau A, Kilic N, et al
Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FU P , Ibusuki M, Yamamoto Y, Hayashi M, et al
Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

RIAZ M , Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, et al
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BUNDRED NJ , Prasad R, Morris J, Knox WF, et al
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WANG Z , Wu LC, Chen JQ
Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHAO S , Liu Y, Zhang Q, Li H, et al
Erratum to: The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

JUNG SY , Sereika SM, Linkov F, Brufsky A, et al
The effect of delays in treatment for breast cancer metastasis on survival.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

REINER AS , Jacks LM, Van Zee KJ, Panageas KS, et al
A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HOLMES MD , Chen WY, Schnitt SJ, Collins L, et al
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

June 2011

MUKHTAR RA , Moore AP, Nseyo O, Baehner FL, et al
Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIU F , Lang R, Zhao J, Zhang X, et al
CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DOMINICI L , Najita J, Hughes M, Niland J, et al
Surgery of the primary tumor does not improve survival in stage IV breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WU AH , McKean-Cowdin R, Tseng CC
Birth weight and other prenatal factors and risk of breast cancer in Asian-Americans.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GIORDANO A , Giuliano M, De Laurentiis M, Eleuteri A, et al
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JAMSHIDI M , Bartkova J, Greco D, Tommiska J, et al
NQO1 expression correlates inversely with NFkappaB activation in human breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

OKISHIRO M , Kim SJ, Tsunashima R, Nakayama T, et al
MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DOMAGALA P , Wokolorczyk D, Cybulski C, Huzarski T, et al
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HOUSSAMI N , Macaskill P, Balleine RL, Bilous M, et al
HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VARGA Z , Tubbs RR, Wang Z, Sun Y, et al
Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PAGANI O , Partridge A, Korde L, Badve S, et al
Pregnancy after breast cancer: if you wish, ma'am.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COLLIE-DUGUID ES , Sweeney K, Stewart KN, Miller ID, et al
SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NANOS-WEBB A , Jabbour NA, Multani AS, Wingate H, et al
Targeting low molecular weight cyclin E (LMW-E) in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHANG L , Wu G, Pantel K
Detection of circulating tumor cells by RT-PCR significantly associated with poor prognosis in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

SPEYER CL , Smith JS, Banda M, Devries JA, et al
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HAAS JS , Liang SY, Hassett MJ, Shiboski S, et al
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TAIRA N , Shimozuma K, Shiroiwa T, Ohsumi S, et al
Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TWELVES D , Nerurkar A, Osin P, Ward A, et al
The anatomy of fluid-yielding ducts in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WU XY , Chen MB, Wang LQ, Xu Y, et al
Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

VICHAPAT V , Garmo H, Holmberg L, Fentiman IS, et al
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

STEBBING J , Filipovic A, Ellis IO, Green AR, et al
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VON MINCKWITZ G , Darb-Esfahani S, Loibl S, Huober J, et al
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer-results from the GeparQuattro study (GBG 40).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JENSEN JD , Knoop A, Ewertz M, Laenkholm AV, et al
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VAN DEN BROEK AJ , Broeks A, Horlings HM, Canisius SV, et al
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GAUDET MM , Press MF, Haile RW, Lynch CF, et al
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

OH E , Choi YL, Park T, Lee S, et al
A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

RIEF W , Bardwell WA, Dimsdale JE, Natarajan L, et al
Long-term course of pain in breast cancer survivors: a 4-year longitudinal study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HADAD S , Iwamoto T, Jordan L, Purdie C, et al
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LANG T , Justenhoven C, Winter S, Baisch C, et al
The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GALLICCHIO L , Macdonald R, Wood B, Rushovich E, et al
Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

XIA TS , Wang GZ, Ding Q, Liu XA, et al
Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIGUMSKY H , Wolf I, Israeli S, Haimsohn M, et al
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

XI B , Zeng T, Liu L, Liang Y, et al
Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SPEARS M , Taylor KJ, Munro AF, Cunningham CA, et al
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ANAN K , Mitsuyama S, Yanagita Y, Kimura M, et al
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SHI H , Bevier M, Johansson R, Grzybowska E, et al
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KIM SJ , Masago A, Tamaki Y, Akazawa K, et al
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

May 2011

SVERRISDOTTIR A , Johansson H, Johansson U, Bergh J, et al
Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GRAHAM P
Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ROMAN R , Sala M, De La Vega M, Natal C, et al
Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LAM WW , Au AH, Wong JH, Lehmann C, et al
Unmet supportive care needs: a cross-cultural comparison between Hong Kong Chinese and German Caucasian women with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FOUKAKIS T , Fornander T, Lekberg T, Hellborg H, et al
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KALINSKY K , Heguy A, Bhanot UK, Patil S, et al
PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DING DP , Zhang Y, He XF
Lack of association between hOGG1 Ser326Cys polymorphism and breast cancer susceptibility in European population.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ALFORD SH , Toy K, Merajver SD, Kleer CG, et al
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHANG J , Pei R, Pang Z, Ouyang T, et al
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

IGNATOV A , Ignatov T, Weissenborn C, Eggemann H, et al
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BAYRAKTAR UD , Kim TK, Drews-Elger K, Benjamin C, et al
Simultaneous measurement of ERalpha, HER2, and PhosphoERK1/2 in breast cancer cell lines by flow cytometry.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

STEVENS KN , Wang X, Fredericksen Z, Pankratz VS, et al
Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SANDHOLM J , Kauppila JH, Pressey C, Tuomela J, et al
Estrogen receptor-alpha and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VACEK PM , Skelly JM, Geller BM
Breast cancer risk assessment in women aged 70 and older.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HE XF , Su J, Zhang Y, Huang X, et al
Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

TUNA M , Smid M, Martens JW, Foekens JA, et al
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ESSERMAN LJ , Moore DH, Tsing PJ, Chu PW, et al
Biologic markers determine both the risk and the timing of recurrence in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ALKNER S
Regarding the article "The p160 ER co-regulators predict outcome in ER negative breast cancer" by Spears, Oesterreich, Migliaccio et al. published in Breast Cancer Res Treat, March 2011.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

PANG Z , Yao L, Zhang J, Ouyang T, et al
RAD51C germline mutations in Chinese women with familial breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

LIU C
Associations between polymorphisms of tumor necrosis factor-alpha gene and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

WILSON KM , Willett WC, Michels KB
Mothers' pre-pregnancy BMI and weight gain during pregnancy and risk of breast cancer in daughters.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

RAZIS E , Bobos M, Kotoula V, Eleftheraki AG, et al
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YAMAMOTO N , Nakayama T, Kajita M, Miyake T, et al
Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARbeta2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DOGGRELL SA
Adherence to oral endocrine treatments in women with breast cancer: can it be improved?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

RAJAN SS , Stearns SC, Lyman GH, Carpenter WR, et al
Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LALISANG RI , Erdkamp FL, Rodenburg CJ, Knibbeler-van Rossum CT, et al
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YAN XL , Fu CJ, Chen L, Qin JH, et al
Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YERUSHALMI R , Gelmon KA, Leung S, Gao D, et al
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

OHSUMI S , Inoue T, Kiyoto S, Hara F, et al
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ALFANO CM , Lichstein KL, Vander Wal GS, Smith AW, et al
Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FU AZ , Chen L, Sullivan SD, Christiansen NP, et al
Absenteeism and short-term disability associated with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HAYES SC , Speck RM, Reimet E, Stark A, et al
Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MANOUKIAN S , Peissel B, Frigerio S, Lecis D, et al
Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ONO M , Tsuda H, Shimizu C, Yamamoto S, et al
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BANYS M , Krawczyk N, Becker S, Jakubowska J, et al
The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KWAN ML , Greenlee H, Lee VS, Castillo A, et al
Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHEN MB , Gu JH, Wu XY, Lu PH, et al
Data in a recent meta-analysis about TNF-alpha polymorphisms and breast cancer susceptibility need for clarification.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

AIRD KM , Allensworth JL, Batinic-Haberle I, Lyerly HK, et al
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

XU F , Zhong D, Tang Z, Zhou M, et al
Association of XPC polymorphisms with breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

LIU Y , Perez M, Schootman M, Aft RL, et al
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LYNCH BM , Friedenreich CM, Winkler EA, Healy GN, et al
Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003-2006).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NSOULI-MAKTABI HH , Henson DE, Younes N, Young HA, et al
Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ALBERT JM , Buzdar AU, Guzman R, Allen PK, et al
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ALSAKER MD , Opdahl S, Asvold BO, Romundstad PR, et al
The association of reproductive factors and breastfeeding with long term survival from breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SETZ-PELS W , Duijm LE, Groenewoud JH, Louwman MW, et al
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ONEGA T , Cook A, Kirlin B, Shi X, et al
The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHOU WB , Ding Q, Chen L, Liu XA, et al
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CASA AJ , Potter AS, Malik S, Lazard Z, et al
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

HILL N , Madarnas Y
Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

BONIFACI N , Palafox M, Pellegrini P, Osorio A, et al
Evidence for a link between TNFRSF11A and risk of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

LI XM , Yan H, Zhou KN, Dang SN, et al
Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

HE XF , Su J, Zhang Y, Ding DP, et al
Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

FU Z , Deming SL, Fair AM, Shrubsole MJ, et al
Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

April 2011

KIM HS , Moon HG, Han W, Yom CK, et al
COX2 overexpression is a prognostic marker for Stage III breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

JOHNSON J , Healey S, Khanna KK, Chenevix-Trench G, et al
Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

HAN J , Jiang T, Bai H, Gu H, et al
Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

MADELEINE MM , Johnson LG, Malkki M, Resler AJ, et al
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

GERBER B , Heintze K, Stubert J, Dieterich M, et al
Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

O'MALLEY FP , Chia S, Tu D, Shepherd LE, et al
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

DESHPANDE AD , Sefko JA, Jeffe DB, Schootman M, et al
The association between chronic disease burden and quality of life among breast cancer survivors in Missouri.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

JANG G , Lee SS, Ahn JH, Jung KH, et al
Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

NYANTE SJ , Gammon MD, Kaufman JS, Bensen JT, et al
Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

BERNSDORF M , Balslev E, Lykkesfeldt AE, Kroman N, et al
Value of post-operative reassessment of estrogen receptor alpha expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

TAO M , Ma D, Li Y, Zhou C, et al
Clinical significance of circulating tumor cells in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

LI Q , Xu F
Association between two polymorphisms of CD166/ALCAM gene and breast cancer risk in Chinese women.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ANBALAGAN M , Carrier L, Glodowski S, Hangauer D, et al
KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor alpha positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LI T , Feng Z, Jia S, Wang W, et al
Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-alpha via activate p38 MAPK signaling pathway.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GILBERT SF , Soliman AS, Iniesta M, Eissa M, et al
Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HE XF , Su J, Wang W
Need for clarification of data in the recent meta-analysis about p53 codon 72 polymorphism and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

MEHTA RJ , Jain RK, Leung S, Choo J, et al
FOXA1 is an independent prognostic marker for ER-positive breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WINTERS-STONE KM , Dobek J, Nail L, Bennett JA, et al
Erratum to: Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

CONROY SM , Maskarinec G, Wilkens LR, White KK, et al
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JOHNSON L , Pinder S, Douek M
Multiple foci of invasive breast cancer: can breast MRI influence surgical management?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LI DM , Feng YM
Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SOMLO G , Lau SK, Frankel P, Hsieh HB, et al
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MUNHOZ AM , Gemperli R, Filassi JR
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

HUA Z , Li D, Xiang G, Xu F, et al
PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHIA S
Trends in improving survival in breast cancer: two steps forward but one step back?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ASCIERTO ML , Kmieciak M, Idowu MO, Manjili R, et al
A signature of immune function genes associated with recurrence-free survival in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CAMPIGLIO M , Bufalino R, Sandri M, Ferri E, et al
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VAN HOESEL AQ , van de Velde CJ, Kuppen PJ, Putter H, et al
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GANZ PA , Habel LA, Weltzien EK, Caan BJ, et al
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LIU C
The association between AURKA T91A polymorphism and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

TAN MH , De S, Bebek G, Orloff MS, et al
Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LI JY , Ou ZL, Yu SJ, Gu XL, et al
The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

AZOULAY L , Yin H, Renoux C, Suissa S, et al
The use of atypical antipsychotics and the risk of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MANDELBLATT JS , Luta G, Kwan ML, Makgoeng SB, et al
Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GILJE B , Nordgard O, Tjensvoll K, Janssen EA, et al
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HARBECK N
Struggling with subtypes: trying to bridge the gap between molecular breast cancer subtypes and clinical management.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

YANG Y , Feng R, Bi S, Xu Y, et al
TNF-alpha polymorphisms and breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PANOFF JE , Hurley J, Takita C, Reis IM, et al
Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SLATTERY ML , Baumgartner KB, Giuliano AR, Byers T, et al
Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CHEN W
Association between rs3803662 polymorphism of trinucleotide repeat containing 9 gene and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

LIPS EH , Mulder L, de Ronde JJ, Mandjes IA, et al
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WANG F , Zou YF, Sun GP
XPC gene polymorphisms and breast cancer susceptibility: appraisal of a recent meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

HURLEY S , Reynolds P, Goldberg D, Nelson DO, et al
Adipose levels of polybrominated diphenyl ethers and risk of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GALIMBERTI V , Botteri E, Chifu C, Gentilini O, et al
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DU J , Li L, Ou Z, Kong C, et al
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

MARTIN M , Romero A, Cheang MC, Lopez Garcia-Asenjo JA, et al
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZOU YF , Wang F, Feng XL
The association between IGF1 CA repeat polymorphisms and breast cancer risk: appraisal of a recent meta-analysis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

GEUTJES EJ , Tian S, Roepman P, Bernards R, et al
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VILLARONGA MA , Lopez-Mateo I, Markert L, Espinosa E, et al
Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

YONG M , Jensen AO, Jacobsen JB, Norgaard M, et al
Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007).
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JACOBS MA , Ouwerkerk R, Wolff AC, Gabrielson E, et al
Monitoring of neoadjuvant chemotherapy using multiparametric, (23)Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VARADI V , Bevier M, Grzybowska E, Johansson R, et al
Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

VILLASENOR A , Ambs A, Ballard-Barbash R, Baumgartner KB, et al
Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PATANI N , Mokbel K
Clinical significance of sentinel lymph node isolated tumour cells in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NAROD SA
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

March 2011

JEZEQUEL P , Campone M, Gouraud W, Guerin-Charbonnel C, et al
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

CANCELLO G , Maisonneuve P, Rotmensz N, Viale G, et al
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WANG ZY , Loo TY, Shen JG, Wang N, et al
LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

SAIEVA C , Peluso M, Masala G, Munnia A, et al
Bulky DNA adducts and breast cancer risk in the prospective EPIC-Italy study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HUANG Y , Vasilatos SN, Boric L, Shaw PG, et al
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LONG M , Jia W, Li S, Jin L, et al
A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

NASCIMBEN MATHEUS C , Caldeira de Oliveira Guirro E
Change in blood flow velocity demonstrated by Doppler ultrasound in upper limb after axillary dissection surgery for the treatment of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PENG S , Lu B, Ruan W, Zhu Y, et al
Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GRANA B , Fachal L, Darder E, Balmana J, et al
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COLLERAN G , McInerney N, Rowan A, Barclay E, et al
Erratum to: The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

MCINERNEY NM , Miller N, Rowan A, Colleran G, et al
Erratum to: Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

LEE CK , Hudson M, Stockler M, Coates AS, et al
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DONG JY , Zhang L, He K, Qin LQ, et al
Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

JIN B , Jiang F, Ding Z
Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ZAMAN K , Durando X, Baurain JF, Humblet Y, et al
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FAGERLIN A , Dillard AJ, Smith DM, Zikmund-Fisher BJ, et al
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

PARK IH , Ro J, Park S, Lim HS, et al
Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GOUNARIS I , Provenzano E, Vallier AL, Hiller L, et al
Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

GRANT WB , Boucher BJ
Low vitamin D status likely contributes to the link between periodontal disease and breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

ZHENG Y , Zhang J, Niu Q, Olopade OI, et al
Germline mutational analysis of the C19orf62 gene in African-American women with breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DE MUNCK L , Schaapveld M, Siesling S, Wesseling J, et al
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

LEMIEUX J , Desbiens C, Hogue JC
Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DING DP , He XF, Zhang Y
Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

WINTERS-STONE KM , Dobek J, Nail L, Bennett JA, et al
Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

BOCKMEYER CL , Christgen M, Muller M, Fischer S, et al
MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

DOMAGALA P , Huzarski T, Lubinski J, Gugala K, et al
PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ERIKSEN C , Frisell J, Wickman M, Lidbrink E, et al
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

FU H , Zhang Y, Jin L, Ding Z, et al
Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles

WONG MW , Nordfors C, Mossman D, Pecenpetelovska G, et al
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

KASTL L , Brown I, Schofield AC
miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

HEALY NA , Glynn RW, Scutaru C, Groneberg D, et al
The h index and the identification of global benchmarks for breast cancer research output.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

ZHAO H , Cui K, Nie F, Wang L, et al
The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COLEMAN R , Woodward E, Brown J, Cameron D, et al
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

COMEN E , Davids M, Kirchhoff T, Hudis C, et al
Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
Breast Cancer Res Treat. 2011.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: